Literature DB >> 17179619

Cutaneous vasculitis as a presenting feature of multiple myeloma: a report of 2 cases.

Priyam S Kembre1, Sunanda Mahajan, Vidya Kharkar, Uday Khopkar.   

Abstract

We report two male patients who presented with symmetrical, painful purpura that evolved into bullae and necrotic ulcers, predominantly on the extremities, over two months in spite of conventional therapy including oral steroids. Examination showed livedoid and purpuric patches with necrotic centers in starburst pattern over the extremities and buttocks. The first case also had similar lesions over the ears. The clinical presentation and the histopathological examination suggested a diagnosis of necrotizing leukocytoclastic vasculitis (LCV). Blood testing ruled out connective tissue disease, hepatitis B or C infection or streptococcal infection as underlying cause of vasculitis. Serum antinuclear factor, antineutrophilic cytoplasmic antibody and anticardiolipin anticoagulant were negative in both cases. Cryoglobulins were positive in case 2. An incidental finding was raised serum proteins and globulins in case 2. Further investigations revealed M band on electrophoresis and features of multiple myeloma on bone marrow biopsy in both cases. These cases emphasize the importance of simple investigations like serum proteins in the evaluation of LCV.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17179619     DOI: 10.4103/0378-6323.29340

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  2 in total

1.  Cutaneous Manifestations of Multiple Myeloma.

Authors:  Binodini Behera; Monali Pattnaik; Bharti Sahu; Prasenjeet Mohanty; Swapna Jena; Liza Mohapatra
Journal:  Indian J Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.494

2.  Multiple Myeloma with Cutaneous Deposits as Rare Lymphoplasmacytoid Cells.

Authors:  Khushboo A Minni; Tharini Gurusamy Karuvelan; Janaki Chellam; Manoharan Krishanaswamy
Journal:  Indian J Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.